Nothing Special   »   [go: up one dir, main page]

TR199501229A2 - Yeni bilesim. - Google Patents

Yeni bilesim.

Info

Publication number
TR199501229A2
TR199501229A2 TR95/01229A TR9501229A TR199501229A2 TR 199501229 A2 TR199501229 A2 TR 199501229A2 TR 95/01229 A TR95/01229 A TR 95/01229A TR 9501229 A TR9501229 A TR 9501229A TR 199501229 A2 TR199501229 A2 TR 199501229A2
Authority
TR
Turkey
Prior art keywords
new composition
composition
new
Prior art date
Application number
TR95/01229A
Other languages
English (en)
Inventor
Hideroni Okhi
Masaki Tomishima
Akira Yamada
Hisashi Takasugi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199501229(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of TR199501229A2 publication Critical patent/TR199501229A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TR95/01229A 1994-10-07 1995-10-06 Yeni bilesim. TR199501229A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound

Publications (1)

Publication Number Publication Date
TR199501229A2 true TR199501229A2 (tr) 1996-07-21

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01229A TR199501229A2 (tr) 1994-10-07 1995-10-06 Yeni bilesim.

Country Status (27)

Country Link
US (2) US6107458A (tr)
EP (1) EP0788511B1 (tr)
JP (2) JP2897427B2 (tr)
KR (1) KR100353303B1 (tr)
CN (1) CN1203089C (tr)
AR (1) AR041770A1 (tr)
AT (1) ATE229541T1 (tr)
AU (1) AU696949B2 (tr)
BR (2) BRPI9504791B8 (tr)
CA (1) CA2202058C (tr)
DE (2) DE69529172T2 (tr)
DK (1) DK0788511T3 (tr)
ES (1) ES2187575T3 (tr)
FI (1) FI119988B (tr)
FR (1) FR08C0028I2 (tr)
HK (1) HK1004136A1 (tr)
HU (1) HU228151B1 (tr)
IL (1) IL115484A (tr)
LU (1) LU91452I2 (tr)
MX (1) MX9702531A (tr)
NL (1) NL300352I2 (tr)
NO (2) NO328483B1 (tr)
OA (1) OA10475A (tr)
PT (1) PT788511E (tr)
RU (1) RU2165423C2 (tr)
TR (1) TR199501229A2 (tr)
WO (1) WO1996011210A1 (tr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process
IL137494A0 (en) * 1998-02-09 2001-07-24 Fujisawa Pharmaceutical Co Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
WO2000047188A1 (en) * 1999-02-11 2000-08-17 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
WO2001007468A2 (en) * 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
WO2002060446A1 (en) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
WO2004014879A1 (en) * 2002-08-08 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. New process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
DE602004010915T2 (de) * 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
WO2005026323A2 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
CA2551037A1 (en) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
WO2005112913A1 (en) * 2004-05-20 2005-12-01 The Scripps Research Institute Transthyretin stabilization
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
TW200624427A (en) 2004-09-20 2006-07-16 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
JP4958785B2 (ja) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼインヒビターとしてのそれらの使用
KR20070065429A (ko) * 2004-10-13 2007-06-22 피티씨 테라퓨틱스, 인크. 피라졸 또는 트리아졸 화합물 및 체세포 변이와 관련된질환을 치료하기 위한 약제의 제조에서 이의 용도
EP2540296A1 (en) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2007043400A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
HUE035249T2 (en) 2007-08-13 2018-05-02 Monsanto Technology Llc Preparations and procedures for controlling nematodes
BRPI0820409A2 (pt) * 2007-10-29 2015-05-19 Astellas Pharma Inc Composto de polipeptídeo
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
EA019001B1 (ru) * 2008-06-24 2013-12-30 Айрм Ллк Соединения и способы модулирования рецепторов, связанных с белком g
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) * 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
ES2547827T3 (es) 2011-04-20 2015-10-08 Axellia Pharmaceuticals Aps Procedimiento para la purificación de la micafungina
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
CN103917531B (zh) * 2011-09-09 2016-08-24 桑多斯股份公司 米卡芬净中间体的制备
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN104861043B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的组合物及其制备方法和用途
US10183973B2 (en) * 2014-05-29 2019-01-22 Shanghai Techwell Biopharmaceutical Co., Ltd. Solvate of cyclic peptide compound, preparation method for same, and uses thereof
EP3226885A4 (en) * 2014-10-07 2018-07-18 Alaparthi, Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
TW264477B (tr) * 1992-03-19 1995-12-01 Lilly Co Eli

Also Published As

Publication number Publication date
FI119988B (fi) 2009-05-29
AU696949B2 (en) 1998-09-24
IL115484A (en) 2000-07-16
ATE229541T1 (de) 2002-12-15
ES2187575T3 (es) 2003-06-16
DE69529172D1 (de) 2003-01-23
NO971544L (no) 1997-06-04
EP0788511A1 (en) 1997-08-13
FI971397A (fi) 1997-05-27
HU228151B1 (en) 2012-12-28
KR970707150A (ko) 1997-12-01
CN1168675A (zh) 1997-12-24
WO1996011210A1 (en) 1996-04-18
IL115484A0 (en) 1996-01-19
CN1203089C (zh) 2005-05-25
DK0788511T3 (da) 2003-03-31
DE122008000025I1 (de) 2008-08-21
BR9504791B1 (pt) 2010-10-05
JPH10324695A (ja) 1998-12-08
FI971397A0 (fi) 1997-04-04
OA10475A (en) 2002-04-08
FR08C0028I2 (tr) 2009-11-20
JP2897427B2 (ja) 1999-05-31
NO328483B1 (no) 2010-03-01
FR08C0028I1 (tr) 2008-08-15
JP3518665B2 (ja) 2004-04-12
US6265536B1 (en) 2001-07-24
NL300352I2 (nl) 2008-11-03
HK1004136A1 (en) 1998-11-20
EP0788511B1 (en) 2002-12-11
NO2010016I2 (no) 2011-10-17
CA2202058A1 (en) 1996-04-18
US6107458A (en) 2000-08-22
BR9504791A (pt) 1996-10-22
DE69529172T2 (de) 2003-04-17
AU3578095A (en) 1996-05-02
JPH10507174A (ja) 1998-07-14
DE122008000025I2 (de) 2011-02-17
HUT77736A (hu) 1998-07-28
RU2165423C2 (ru) 2001-04-20
NO971544D0 (no) 1997-04-04
NO2010016I1 (no) 2010-08-16
PT788511E (pt) 2003-04-30
AR041770A1 (es) 2005-06-01
LU91452I2 (fr) 2008-08-04
BRPI9504791B8 (pt) 2019-12-31
NL300352I1 (nl) 2008-08-01
CA2202058C (en) 2007-11-06
KR100353303B1 (ko) 2003-01-15
MX9702531A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
TR199501229A2 (tr) Yeni bilesim.
TR199501597A2 (tr) Yeni bilesikler.
TR199700090A2 (tr) Yeni heteroaril-oksazolidinonlar.
TR199501655A2 (tr) Yeni monosiklik -laktam bilesikleri.
TR199600096A2 (tr) Yeni bilesikler.
TR199501406A2 (tr) Kirisiklik giderme bilesimi.
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
FI951772A (fi) 3,5-disubstituoidut tetrahydrofuran-2-onit
FI954773A (fi) Antihypertriglyserideeminen koostumus
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
TR199500945A1 (tr) Sübstitüe edilmis bifeniloksazolinler.
ITMI940362A0 (it) Composizione antitosse
TR199501320A2 (tr) Anti- aritmik maddeler olarak faydali yeni bilesikler.
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
DK0804088T3 (da) Stabiliseret sammensætning, der omfatter solisinsulfat
TR199501486A2 (tr) Yeni sülfonamidler.
TR199501465A2 (tr) Yeni toksinler.
TR199500947A1 (tr) Yeni yüzeyaktif maddeler.
ATE197594T1 (de) Verbesserte, änderbare zusammensetzung
TR28973A (tr) Plastisol bilesimi.
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
FR2720962B1 (fr) Baguetteuse.
IT234659Y1 (it) Sottosella.
TR199500896A2 (tr) Yeni bilesik.
FR2714950B3 (fr) Réducteur-variateur.